US Patent 9226932 Phosphoramidate alkylator prodrugs

Patent 9226932 was granted and assigned to Threshold Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Threshold Pharmaceuticals

Current Assignee

Threshold Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9226932

Patent Inventor Names

Mark Matteucci0

Hailong Jiao0

Jian-Xin Duan0

Date of Patent

January 5, 2016

Patent Application Number

14102213

Date Filed

December 10, 2013

Patent Primary Examiner

‌

Sun Jae Yoo

Patent abstract

Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9226932 Phosphoramidate alkylator prodrugs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API